Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ceramide analogue with promising pharmacological profile presented at recent cancer symposium

Nov. 20, 2000

Bexxar BLA filing accepted by FDA

Nov. 20, 2000

Cell Therapeutics seeks European approval of Trisenox

Nov. 20, 2000

FDA approves IND for Indena/Bayer anticancer compound

Nov. 20, 2000

Cellular effects and mechanism of action of new pteridine derivative discussed at NCI-EORTC-AACR

Nov. 17, 2000

Shionogi's U.S. subsidiary identifies specific antitumor agents with a cyanoguanidine structure

Nov. 17, 2000

New water-soluble quinazoline antitumor agent CB-300919 profiled at NCI-EORTC-AACR meeting

Nov. 17, 2000

Menarini investigates how sugar modifications affect antitumor activity of new anthracyclines

Nov. 17, 2000

ERA-923: a new SERM developed for the treatment of metastatic breast cancer

Nov. 17, 2000

Tumor-selective DPD inhibitor Ro-09-4889 designed to enhance capecitabine efficacy

Nov. 17, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...